03:48 PM EST - Cipher Pharmaceuticals Inc. : announced its financial and operational results for fiscal year ended December 31, 2010. Net revenue increased 70% to $5.4 million versus $3.2 million in 2009. Net income for the 12 months ended December 31, 2010 increased to $100,000 ($0.00 per share), compared with a net loss of $2.7 million ($0.11 per share) in 2009. Cipher Pharmaceuticals Inc.
shares T.DND are trading down $0.14 at $1.04.